Contact
Home • Our expertise • Medical & Scientific Affairs • Asset Development

Asset Development.

Maximize the potential of your asset.

See our full suite of Medical & Scientific Affairs services

What we do.

Our global medical team brings deep industry expertise, scientific rigor, and proven frameworks to support you in developing your asset.

We leverage our knowledge of clinical trials, RWD/RWE, EMR and claims data, HEOR, and country requirements to ensure every asset has a fit-for-purpose plan for success.

How we help.

Through systematic scientific rigor and analysis using proven frameworks, we can help you develop a robust asset development plan by:

  • Determining indication and endpoint prioritization
  • Identifying registrational pathways and frameworks
  • Providing companion diagnostic considerations
  • Assessing the medical landscape and patient journey
  • Aligning on a scientific narrative
  • Providing medical input into target product profiles
  • Analyzing medical evidence gaps
  • Generating integrated medical evidence plans
  • Creating lifecycle management plans

Featured case study.

Asset medical lifecycle plan

We developed an indication expansion strategy for a client given new regulatory guidance that would impact a breakthrough vaccine.
View all case studies
Featured

Asset medical lifecycle plan

US and EU regulatory agencies provided the client with new guidance on generating supportive evidence for the proposed launch indication and future.

Read more

Get to know some of our experts.

Lori Klein, PharmD

Partner, Medical and Scientific Affairs Practice Lead

Read bio

Erika Ray, PhD

Manager

Read bio

Ryan Wyrtzen

Partner

Read bio

Latest thinking.

Get the latest insights and perspectives from our experts.

View all of our resources

Trends in Medical Affairs at MAPS 2023 annual meeting

The evolution of Medical Affairs as a pivotal strategic leader at this year’s sold-out Medical Affairs Professional Society (MAPS).

Read more

Asset medical lifecycle plan

US and EU regulatory agencies provided the client with new guidance on generating supportive evidence for the proposed launch indication and future.

Read more

AI algorithm landscape assessment

Read how our client aims to locate organizations advancing AI algorithms for rare disease detection.

Read more

Local medical launch readiness plans

Putnam helped the client to support development of local medical launch readiness plans for a new vaccine.

Read more

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.

Contact us today

Related offerings.

Medical & Scientific Affairs

Learn more

Launch Strategy

Learn more

Digital Health & Omnichannel Strategy

Learn more
View all of our areas of expertise